In kidney transplant recipients, surveillance biopsies can reveal, despite stable graft function, histologic features of acute rejection and borderline changes that are associated with undesirable graft outcomes...
Read More »PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics partner to develop clinically validated RNA-Seq workflow for whole blood samples
Hombrechtikon, Switzerland, San Carlos, CA, Piscataway, NJ, January 27, 2015 — PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to validate an end-to- end workflow for the reproducible collection and processing of whole ...
Read More »